Diseased skeletal muscle: a noncardiac source of increased circulating concentrations of cardiac troponin T.

[1]  A. Khera,et al.  Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. , 2010, JAMA.

[2]  Mario Plebani,et al.  Recommendations for the use of cardiac troponin measurement in acute cardiac care. , 2010, European heart journal.

[3]  R. Niska,et al.  National Hospital Ambulatory Medical Care Survey: 2007 emergency department summary. , 2010, National health statistics reports.

[4]  J. Case,et al.  Serum Cardiac Troponin T, But Not Troponin I, Is Elevated in Idiopathic Inflammatory Myopathies , 2009, The Journal of Rheumatology.

[5]  Jeroen J. Bax,et al.  The heart in sporadic inclusion body myositis: a study in 51 patients , 2009, Journal of Neurology.

[6]  Timothy Day,et al.  Prevalence of sporadic inclusion body myositis and factors contributing to delayed diagnosis , 2008, Journal of Clinical Neuroscience.

[7]  R. Niska,et al.  National Hospital Ambulatory Medical Care Survey: 2006 emergency department summary. , 2008, National health statistics reports.

[8]  Fred S Apple,et al.  Universal definition of myocardial infarction. , 2007, Journal of the American College of Cardiology.

[9]  R. Tawil,et al.  Facioscapulohumeral muscular dystrophy , 2006, Muscle & nerve.

[10]  Robert H Christenson,et al.  Stratus CS cardiac troponin I method: performance characteristics including imprecision at low concentrations. , 2004, Clinical biochemistry.

[11]  F. Breedveld,et al.  Epidemiology of inclusion body myositis in the Netherlands: A nationwide study , 2000, Neurology.

[12]  F. Apple,et al.  RNA expression of cardiac troponin T isoforms in diseased human skeletal muscle. , 1999, Clinical chemistry.

[13]  F. Apple,et al.  Cardiac troponin T isoforms expressed in renal diseased skeletal muscle will not cause false-positive results by the second generation cardiac troponin T assay by Boehringer Mannheim. , 1998, Clinical chemistry.

[14]  A. Remppis,et al.  Cardiac troponin T in patients with end-stage renal disease: absence of expression in truncal skeletal muscle. , 1998, Clinical chemistry.

[15]  A. Remppis,et al.  Improved troponin T ELISA specific for cardiac troponin T isoform: assay development and analytical and clinical validation. , 1997, Clinical chemistry.

[16]  F. Apple,et al.  Cardiac troponin T composition in normal and regenerating human skeletal muscle. , 1997, Clinical chemistry.

[17]  F. Apple,et al.  Cardiac troponin-I is not expressed in fetal and healthy or diseased adult human skeletal muscle tissue. , 1995, Clinical chemistry.

[18]  B. Kay,et al.  Molecular basis of human cardiac troponin T isoforms expressed in the developing, adult, and failing heart. , 1995, Circulation research.

[19]  A. Remppis,et al.  Development and in vitro characterization of a new immunoassay of cardiac troponin T. , 1992, Clinical chemistry.

[20]  P Halonen,et al.  [Facioscapulohumeral muscular dystrophy]. , 1990, Duodecim; laaketieteellinen aikakauskirja.

[21]  J. Wilkinson,et al.  Comparison of amino acid sequence of troponin I from different striated muscles , 1978, Nature.